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individual variability in appetite through
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Junhee Lee1*, Jiwon Lee1, Hyunshang Shin1, Ki-Suk Kim2, Euiju Lee1, Byunghee Koh1 and Hyeung-Jin Jang2*Abstract
Background: Appetite is intricately connected to eating behaviors and shows a high individual variability. In an
attempt to approach the problem of gut hormone profiles, appetite, and eating behaviors at the individual level,
we have adopted a constitutional typing system widely used in traditional East-Asian medicine, the Sasang
constitutional typology, in order to determine the individual variations in appetite, eating behavior, and weight
change.
Methods: This pilot study was designed to investigate the variability of appetite among individuals by tracking the
gut hormone patterns across different constitutional types. Pre- and post-prandial concentrations of anorectic
(peptide YY (PYY), glucagon-like peptide 1 (GLP-1)) and orexigenic (active ghrelin) gut hormones were measured in
healthy, normal-weight (18.5 kg/m2 ≤BMI <23 kg/m2) male subjects aged 20–35 (Soyang (SY) (n = 9), Taeeum (TE)
(n = 9), and Soeum (SE) (n = 10) constitutional types).
Results: Significant differences were found only in the PYY concentrations across the three groups (p = 0.031). The
PYY concentration peaked at 30-min post-prandial in the SE group and was significantly higher compared to the
other two groups (p = 0.004). The GLP-1 concentration peaked at 15-min post-prandial in the SE group (not
significant). The ghrelin levels at 30-min pre-prandial were relatively lower in the TE group compared to the other
groups (not significant).
Conclusions: In conclusion, although with weak statistical power, meaningful gut hormone patterns specific to
each constitutional type were discovered in this pilot study, which could offer a new method of approaching the
problem of appetite and eating behavior from the angle of individual variability in appetite.
Keywords: Gut hormone, Appetite, Eating behavior, Sasang constitutional typologyBackground
The gastrointestinal tract is the largest endocrine organ that
secretes the gut hormones that play important roles in en-
ergy metabolism and weight control. Several gut hormones
have been discovered so far, of which many are closely asso-
ciated with appetite and systemic metabolism [1,2]. Appetite
is also closely related to eating behavior and shows a high
variability among different individuals [3]. Many studies* Correspondence: ssljh@daum.net; hjjang@khu.ac.kr
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reproduction in any medium, provided the orhave been conducted based on this close association
between gut hormones, appetite, and metabolism. Some
studies on gut hormone profiling and appetite have com-
pared the healthy population versus unhealthy population
(e.g. populations with obesity or anorexia nervosa) [1], and
some have investigated the genetic associations of appetite
and gut hormones in the healthy population [4-6]. However,
except these population-based studies, no study has yet
explored the appetite patterns at the individual level
through gut hormone profiling.
In clinical settings, case-specific traits of individual pa-
tient can be more meaningful for predicting his or her
physiologic and pathologic status than average features of
the whole population. For this reason, healthcare providers. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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clinical standards to infer pathological patterns of patients
and to make medical decisions. Especially concerning
medical subjects of complex nature, such as appetite and
eating behavior, many agree that an approach from a dif-
ferent angle factoring in the individually diversified consti-
tutional make-up of an individual would be more efficient.
In one such attempt, we have explored the individualized
patterns of appetite and eating behaviors through a widely
used constitution typing system, the Sasang constitutional
typology.
The Sasang constitutional medicine (SCM) is a compo-
nent of traditional Korean medicine that studies the typing
of individuals into four constitutional types Taeyangin (TY
type), Soyangin (SY type), Taeeumin (TE type) and Soeumin
(SE type) based on their physical and psychological attri-
butes (Table 1) [7,8]. The physiology, pathology, and thera-
peutics specific to each constitutional type have been
explored extensively in many studies [9]. Several recent
studies also report different prevalence rates of chronic dis-
eases across different Sasang constitutional types, in obesity
[10,11], insulin resistance [12], diabetes mellitus [13], hyper-
tension [14], metabolic syndrome [15], and cerebrovascular
diseases [16,17], providing scientific evidence of the well-
recognized patterns already witnessed by clinicians.
These studies show that the Sasang constitutional
typology could be a useful tool in approaching the pa-
tient from the patient-specific or constitution-based
angle, and indeed many practitioners had been suc-
cessfully using the Sasang typology in educating
patients and predicting pathological progressions. In
particular, SCM suggests that different Sasang consti-
tutional types exhibit different clinical traits in appe-
tite, eating behavior, and weight change [7,18].
This pilot study was designed to investigate for the first
time the variability of appetite among individuals across
different Sasang constitutional types by tracking the pre-
and post-prandial concentrations of the anorectic gut hor-
mones (peptide YY (PYY), and glucagon-like peptide 1Table 1 General characteristics of the four Sasang constitutio
TY type SY type
Hyperactive organ system Lung* Spleen*
Hypoactive organ system Liver* Kidney*
Insidious greed and deviations Indiscipline, Ignobility Pretentio
Personality Communicative, decisive Forceful,
Sign of health Plentiful urination Brisk pers
Sign of illness Restricted urination Obstructe
* These represent the functional and structural conceptualization of organs specific
namesake organs in Western medicine. In Sasang constitutional medicine, the varie
four organ systems that represent the following roles in the body: the Lung system
system in concentrating the energy-fluid material, the Spleen system in the contain
water-food material.




We recruited male subjects aged 20–35, who were in
normal weight range (18.5 kg/m2 ≤BMI <23.0 kg/m2)
and confirmed on their Sasang constitutional types
(SY, TE, or SE). The inclusion and exclusion criteria are
presented in Table 2. This study was conducted accord-
ing to the guidelines laid down in the Declaration of Hel-
sinki and all procedures involving human subjects were
approved by the Institutional Review Board at the Hos-
pital of Korean Medicine of Kyung Hee University. Writ-
ten informed consent was obtained from all subjects
with full understanding of the purpose and procedure of
the study.
All applicants were surveyed beforehand on their
demographic characteristics, past medical history, and
lifestyle patterns. The screening also included body size
measurement, blood tests, questionnaires (Bulimia Test
Revised (BULIT-R) [19], Korean Version of Eating Atti-
tude Test-26 (KEAT-26) [20], Gastrointestinal Symptom
Rating Scale (GSRS) [21], and Dutch Eating Behavior
Questionnaire (DEBQ) [22,23]), and Sasang constitu-
tional typing. GSRS and DEBQ were each used to assess
the overall gastrointestinal symptoms and the eating
behaviors of the participants. After non-eligible appli-
cants were screened out, the remaining participants were
assigned identification codes, and all personal and identi-
fying information was blinded from the researchers until
the end of trial.
Of the initial 57 applicants, 7 were eliminated due to
high BMI and 1 for showing anomalous eating patterns.
Sasang constitutional typing was performed on the
remaining 49, and 14 whose constitutional typing by two
specialists did not match each other were dropped. After
further eliminating 3 who showed abnormal blood test
results and 1 who withdrew initial consent, 31nal types
TE type SE type
Liver* Kidney*
Lung* Spleen*
usness, Frivolity Acquisitiveness, Avarice Stealthiness, Prevarication
strong-willed Consistent, reliable Prudent, composed
piration Easy defecation Comfortable digestion
d perspiration Hindered defecation Strained digestion
to the Sasang constitutional typology that are completely different from their
gated functions of the human body is summarized into the interactions of the
is involved in the process of dispersing the energy-fluid material, the Liver
ing of the water-food material, and the Kidney system in discharging of the




- 18.5 kg/m2 ≤Body mass index (BMI) <23 kg/m2
- Sasang-constitutionally typed as either the SY, the TE, or the SE type
Exclusion- History of impaired fasting glucose or diabetes mellitus (past history of diabetes or fasting blood glucose at screening ≥100 mg/dl)
- History of liver disease (hepatitis, hepatic cirrhosis) or hepatic dysfunction (AST or ALT at screening ≥40 U/L)
- History of renal dysfunction (creatinine at screening ≥1.2 mg/dl)
- History of heart disease (heart failure, angina pectoris, myocardial infarction, arrhythmia)
- History of malignant tumor
- Possibility of anorexia nervosa, bulimia nervosa, or other similar disorders (applicants satisfying the DSM-IV criteria for eating disorder and
those who scored ≥88 in the Bulimia Test Revised or ≥21 in the Korean Version of Eating Attitude Test-26 were eliminated)
- Having digestive disorders that can interfere with normal absorption of standard diet (gastritis, gastric ulcer, duodenitis, duodenal ulcer, etc.)
- Smoking during the recent 3 months
- Alcohol consumption 3 or more times a week during the recent 3 months
- Weight change greater than ±2 kg during the recent 3 months
- Anomalous eating pattern (skipping breakfast or having breakfast before 6AM or after 10AM)
- Medicated during the recent month for therapeutic or prophylactic purposes
- Participating in another clinical trial
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(n = 10), TE (n = 11), and SE (n = 10) types).Sasang constitutional typing
Two SCM specialists examined the participants and deter-
mined their constitutional types based on their physical,
mental, physiological, and pathological attributes. The
SCM specialists were qualified traditional Korean medical
doctors licensed by the Korean government, with six years
of traditional Korean medicine training, minimum three
years of training in SCM, and nine years of further clinical
experience. The two specialists were mutually blinded, and
used structured and pre-determined questionnaire to im-
prove objectiveness of decision making. The constitutional
type was confirmed only when both made concordant
decisions. Of the 49 who were examined by the specialists,
35 were typed identically, yielding a diagnostic synchron-
icity of 71.4%.Experimental procedure
The subjects were given information on the study protocol
3 days beforehand and were forbidden to exercise, drink
alcohol, overeat, or fast during the 48 hours preceding the
trial. Each was distributed a standard meal (800 kcal liquid
diet (Medifood Standard, Korea Medical Foods Co., Ltd);
58% carbohydrate, 15% protein, 27% lipid) to be ingested
between 6PM and 7PM on the day before trial to be fol-
lowed by fasting from 8PM onward.On the day of trial, participants arrived at 7AM, shortly
after which the height, weight, and body composition were
measured, and trained nurses inserted intravenous cathe-
ters for blood sampling. Samples for basic blood test (fast-
ing blood glucose, insulin, triglyceride, total cholesterol,
high density lipoprotein cholesterol, and low density lipo-
protein cholesterol) were taken simultaneously. After
60 minutes of rest, they were given 10 minutes to ingest
the 800 kcal standard diet. Samples were taken at six time-
points– 30-minutes pre-prandial, immediately before in-
gestion, and 15, 30, 60, 120-minutes post-prandial. The
participants were asked to remain seated throughout the
experiment (allowing only light activities such as writing,
reading, watching video, talking, using the toilet, etc.) and
were prohibited from exercising or sleeping.Sample processing
Blood samples were collected in ice-cooled Vacutainer
EDTA-plasma tubes. Immediately (< 30 seconds) after
sampling, DPP-IV inhibitor (Linco Cat # DPP4) was added
in accordance to the manufacturer’s instructions (10 μl
DPP-IV inhibitor per milliliter of blood), and the tube was
inverted to mix and stored in ice bath. Immediately after-
wards, sampling tubes were centrifuged at 1000 xg for
10 minutes and stored at −70°C to be analyzed afterwards
in ELISA.
The ELISA method (using ELISA KIT, 96-well plate
(Millipore, Missouri, USA)) was used to assay the plasma
concentrations of GLP-1, PYY, and ghrelin. The assay
Table 3 Characteristics of participants in different Sasang constitutional groups
SY type TE type SE type p-value
(n = 9) (n = 9) (n = 10)
Age (year) 23.0 (20.0, 27.0) 22.0 (20.0, 24.0) 22.5 (20.0, 25.0) 0.975
Height (cm) 178.2 (165.1, 187.7) 178.5 (166.8, 182.6) 175.2 (163.8, 184.3) 0.414
Weight (kg) 71.4 (58.9, 76.4) a 72.1 (63.5, 76.2) a 61.2 (55.1, 67.7) b 0.003
Body mass index (kg/m2) 21.6 (20.2, 23.0) b 22.5 (21.9, 23.0) a 20.0 (18.6, 21.7) c 0.000
Waist circumference (cm) 77.5 (69.8, 85.0) 82.0 (74.8, 84.3) 76.5 (69.5, 79.0) 0.059
Hip circumference (cm) 95.5 (85.7, 100.0) 96.5 (92.5, 102.5) 93.4 (85.5, 99.0) 0.096
Pulse rate (/min) 78.0 (66.0, 84.0) 72.0 (66.0, 84.0) 72.0 (60.0, 84.0) 0.319
Systolic blood pressure (mmHg) 105.0 (85.0, 135.0) 117.5 (95.0, 135.0) 102.5 (95.0, 110.0) 0.257
Diastolic blood pressure (mmHg) 70.0 (60.0, 85.0) 70.0 (60.0, 85.0) 70.0 (50.0, 75.0) 0.683
Fasting glucose (mg/dL) 85.0 (77.0, 91.0) 89.0 (78.0, 101.0) 83.0 (79.0, 92.0) 0.354
Triglyceride (mg/dL) 66.0 (32.0, 95.0) 61.0 (31.0, 230.0) 57.5 (41.0, 136.0) 0.841
Total cholesterol (mg/dL) 147.0 (130.0, 180.0) 148.0 (102.0, 187.0) 148.0 (119.0, 174.0) 0.944
HDL cholesterol (mg/dL) 56.0 (42.0, 70.0) 57.0 (37.0, 79.0) 59.0 (50.0, 79.0) 0.758
LDL cholesterol (mg/dL) 89.0 (79.0, 111.0) 79.0 (58.0, 121.0) 83.5 (53.0, 116.0) 0.520
Insulin (μU/mL) 5.6 (3.7, 10.1) 7.1 (3.5, 18.1) 7.4 (4.4, 18.7) 0.494
HOMA-IR 1.1 (0.7, 2.1) 1.5 (0.7, 4.1) 1.4 (0.8, 4.2) 0.483
KEAT-26 3.0 (0.0, 13.0) 0.0 (0.0, 12.0) 3.5 (0.0, 10.0) 0.232
BULIT-R 47.0 (31.0, 87.0) ab 45.0 (31.0, 54.0) a 38.5 (31.0, 44.0) b 0.037
DEBQ Restraint 24.0 (17.0, 37.0) 25.0 (12.0, 34.0) 15.0 (11.0, 25.0) 0.044
Emotional 19.0 (13.0, 50.0) 23.0 (13.0, 34.0) 13.5 (13.0, 18.0) 0.060
External 32.0 (19.0, 45.0) 28.0 (25.0, 36.0) 25.0 (14.0, 37.0) 0.396
GSRS 3.0 (1.0, 6.0) 3.0 (0.0, 7.0) 2.5 (0.0, 9.0) 0.677
All values are presented as median (minimum, maximum).
abc Values in the same row that are marked with different superscript alphabets are significantly different (p <0.017).
HOMA-IR, homeostasis model assessment of insulin resistance; KEAT-26, the Korean Version of Eating Attitude Test-26; BULIT-R, Bulimia Test Revised; DEBQ, Dutch
Eating Behavior Questionnaire; GSRS, Gastrointestinal Symptom Rating Scale.
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standard sample as positive control. Two kinds of quality
control solutions were provided in each kit. All controls
and samples were added to the well in pairs. All proce-
dures were correctly performed according to the manufac-
turer’s instructions. Fluoroskan Ascent FL (MTX
Labsystems, VA, USA) was used to obtain raw data. Miss-
ing data was found across three or more time-points in 3
of 31 participants’ samples (1 in the SY group and 2 in the
TE group) and therefore omitted in the final analysis.Statistical analysis
All values are presented as median (minimum, maximum).
Kruskal-Wallis test was performed for a three-group ana-
lysis for variables with single assessment, and multiple com-
parison using the Mann–Whitney U test was performed
(employing two-tailed Bonferroni-corrected p-value of
<0.017 to minimize type I error). Generalized estimating
equation for repeated-measures was used to analyze the
gut hormone levels to detect group-by-time interactions,
group-by-BMI interactions and inter-group differences. TheKruskal-Wallis test and multiple comparisons using the
Mann–Whitney U test were done similarly for the inter-
group comparison of the appetite-regulating hormones at
each time-point. All statistical analyses were performed
using the PASW Statistics 18.0 for Windows (Chicago, IL).Results
General characteristics
All subjects were within normal BMI range, but the SE
type weighed significantly less than the SY and TE types
(p = 0.002), the BMI being highest in the TE group and
lowest in the SE group (p <0.001). Waist circumference,
hip circumference, blood pressure, pulse rate, fasting glu-
cose level, and lipid profiles were not significantly differ-
ent across the three constitutional types.
Eating attitude (assessed by KEAT-26) was normal in all
three groups, and bulimic tendency (assessed by BULIT-R)
was also normal in all the groups, though significantly
higher in the TE type compared to the SE type. When the
eating behavior (assessed by DEBQ) was compared,
restraint eating showed significant difference across all
Figure 1 Distributions of pre- and post-prandial gut hormone levels. The horizontal lines in each figure are means.
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cant in multiple comparison). When the overall gastro-
intestinal symptoms (using GSRS) were evaluated, none of
the three constitutional types showed remarkable symp-
toms, and no significant inter-group difference was discov-
ered (p=0.677) (Table 3).Gut hormone profiling
The pre- and post-prandial gut hormone levels of all
subjects were shown in Figure 1. The distributions of gut
hormone levels, especially ghrelin at 30-minutes pre-
prandial, were rather wide due to the small sample size.
Time-group interaction was found in GLP-1, PYY, and
ghrelin, but there were no group-by-BMI effects. The SE
group showed a peak in the GLP-1 concentration at 15-
minutes post-prandial, in contrast to its absence in the TE
and SY curves. At 15-minutes post-prandial, the SE GLP-1level was higher than that of the other two groups, but not
with statistical significance (p=0.096) (Figure 2-A).
The SE group displayed a marked peak in the PYY con-
centration at 30-minutes post-prandial, but this peak was
absent in the TE and SY groups. At 30-minutes post-pran-
dial, the PYY level in the SE group was significantly higher
compared to the other two groups (p= 0.004) (Figure 2-B).
The ghrelin levels at 30-minutes pre-prandial in the SE
and SY groups were relatively higher compared to that of
the TE group. However, none of the time-points yielded
significant inter-group differences (Figure 2-C).Discussion
When gut hormone profiles (GLP-1, PYY, and ghrelin) were
analyzed in healthy, normal-weight, male subjects, gut hor-
mone patterns were found to vary across different Sasang
constitutional types.
Figure 2 Pre- and post-prandial plasma levels of gut hormones across different Sasang constitutional types. Plotted in each figure are
means and standard error of mean (SEM). (A) Glucagon-like peptide (GLP-1) (B) Peptide YY (PYY) (C) Ghrelin. Asterisk (*) denotes significant
difference between different Sasang constitutional types at each time-point (p <0.017).
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group displayed a peak in PYY levels 30 minutes after food
intake, which was absent in the SY and TE groups. Fur-
thermore, the PYY level at the 30-minutes post-prandial
time-point was significantly higher in the SE group than in
the other two groups. This presence of a marked post-
prandial PYY peak found only in the SE group could be
suggestive of strong PYY-mediated appetite suppression in
the SE type as compared to the other constitutional types.
PYY is an anorectic gut hormone related to satiety induc-
tion that increases in the bloodstream approximately
15 minutes following food intake, reaching peak levels at
1–2 hours and remaining elevated for several hours there-
after [24]. The SE constitutional type is known to display
low appetite, small eating capacity, and greater dyspeptic
tendencies, in contrast to the TE type who shows higher
appetite, larger eating capacity, and greater risk for over-
weight and obesity. When these constitutional traits well-
documented in literature are connected with thephysiological role of PYY as a satiety factor, it could ex-
plain the accentuated post-prandial PYY peak in the SE
group and the blunted post-prandial response in the TE
group. Also, post-prandial PYY response is known to be
blunted in obese persons [25], and the fact that the
normal-weight TE group in our study shows this pattern
could be interpreted as supporting the higher prevalence
and risk for obesity found in the TE type in previous
studies.
Other potentially meaningful gut hormone patterns were
found in GLP-1, that could be interpreted in context of
the known traits specific to each constitutional type. There
was a peak in the GLP-1 curve in the SE type at 15-
minutes post-prandial, although no significant difference
was detected when compared with the SY or TE groups.
GLP-1, an anorectic gut hormone [26], is released by food
intake, upon which its circulating concentration increases
biphasically within 10 minutes, peaking at 30 minutes, and
remains elevated for several hours [27]. This pattern of
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a role in meal termination and possibly in generating sati-
ety and delaying gastric emptying [28]. Though not signifi-
cant, it is interesting that only the SE group showed a
post-prandial peak in GLP-1 in light of the known traits of
the SE and TE constitutional types.
The TE group failed to display an elevation in ghrelin
level prior to food ingestion and showed a relatively lower
(though not significant) ghrelin concentration compared
to the SE and SY groups at 30-minutes pre-prandial. In lit-
erature, the plasma level of ghrelin, the only gut hormone
known to increase food intake, rises before the start of a
meal and drops again shortly after meal initiation [29].
Studies show that individuals with high BMI actually dis-
play low circulating ghrelin, lack the typical ghrelin spikes
throughout the day coincident with meal times, and fail to
show the drop-response to a meal [30,31]. The low pre-
meal ghrelin in the TE constitutional type may be asso-
ciated with their overweight tendencies reported in previ-
ous studies. However, the TE subjects in our study were
not actually obese, so the low pre-meal ghrelin is not
wholly explained by overweight status, indicating that the
TE constitutional trait in itself could contribute as an inde-
pendent factor to this particular ghrelin pattern.
In Sasang constitutional typology, it is generally under-
stood that the SE type has smaller appetite and poor eating
capacity, contrasting with the TE type who displays larger
appetite and better eating capacity. Our study showed nor-
mal gut hormone profiles in the SE type, whereas the other
types displayed several abnormal patterns, despite being
normal-weight, and this may hint at disruptions in their
appetite-controlling pathways that can eventually lead to
aberrant eating behaviors or overweight/obesity. Especially,
the strong association between obesity and the TE consti-
tutional type is supported by many studies [32-34].
The limitations of our study are as follows: First, this was a
pilot study, and the sample size was not large enough to con-
fer great statistical power. Second, the ELISA method was
used rather than radioimmunoassay, lowering the overall ac-
curacy. Third, subjects were included only if both specialists
gave identical constitutional typing, eliminating a large group
(n=14 of 49) from the initial applicants. This may have led
to selection bias, and yet it was the most reasonable method
possible (while maintaining maximal accuracy) considering
the difficulties of including the comprehensive process of
routine constitutional typing in this small-scale study. These
problems should be addressed in future, larger-scale studies.
Though no final conclusions can be drawn from this
pilot study, it is significant in that it approaches the asso-
ciation between gut hormone, appetite, and eating be-
havior through a different perspective, from the angle of
individually diversified constitutional make-up, and also
in that it is the first research on gut hormone profiles in
different Sasang constitutional types.Conclusions
Upon examining the gut hormone profiles in healthy,
normal-weight male subjects, meaningful gut hormone
patterns specific to each Sasang constitutional type were
discovered. Though the statistical power of this pilot
study was weak, it nevertheless opens up new possibil-
ities in future investigations on individual variability in
appetite.
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